Abstract
Background
Laparoscopic sleeve gastrectomy (LSG) is basically unknown as a stand-alone technique for bariatric surgery in children and adolescents. It may be advantageous for this age group though, since it requires neither foreign body placement nor life-long malabsorption. We present the first report about the efficacy of LSG in a small pediatric series.
Methods
All patients (n = 4, female) had been in a multi-modal weight loss program for several years without long-term success. At referral, the mean age was 14.5 years (range 8–17), mean body mass index (BMI in kg/m2) was 48.4 (range 40.6–56.3). All suffered from various features of a metabolic-vascular syndrome like diabetes, dislipidemia, cholecystolithiasis, arterial hypertension. The 8-year-old girl was diagnosed Prader–Willi Syndrome at the age of 2. The decision for bariatric surgery was taken unanimously by the parents, patient, and the obesity team. LSG was performed in a five-trocar technique. With a gastroscope (size 40-F) protecting the lesser curvature, the stomach was resected from the proximal antrum to the angle of His using an ENDO-GIA stapler. The stapler line was secured by a continuous suture 3–0 vicryl.
Results
There were no intra- or postoperative complications. Contrast studies confirmed a J-like gastric remnant (mean volume 76 ml) and ruled out leaks in all cases. After a mean follow-up time of 12 months (range 6–19 months), all the patients had reduced weight (mean BMI to 37.2). The girl with the longest postoperative period went from 121 to 83 kg (BMI from 40.6 to 28.4). Laboratory studies ruled out malnutrition or vitamin deficiency. Monitoring of metabolic parameters showed gradual improvement or even resolution for most features.
Conclusion
At a 1-year follow-up, LSG proved a safe and effective option for bariatric surgery in children, achieving moderate weight loss and improvement of comorbidities. Thus, it may be considered as stand-alone technique. Long-term studies however must compare these results with time-tested procedures like gastric banding and Roux-en-Y gastric bypass.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Morbid obesity represents a major medical and socio-economical problem in many industrialized countries today, even among children and adolescents [1, 2]. Prevalence as well as severity of adiposity-associated comorbidities like dyslipidemia, glucose intolerance, and arterial hypertension are increasing dramatically. Some children fail to respond to behavioral interventions and pharmacotherapy [2]. Thus, bariatric surgery remains the last choice for morbidly obese children, and specific guidelines have been established [3]. However, the appropriate surgical technique remains a matter of vivid discussions [4]. Laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass (RYGB) have been adopted from adulthood bariatric surgery [5], although the long-term sequalae of neither technique is clear for children today [6]. Laparoscopic sleeve gastrectomy (LSG) is known as a beneficial weight loss procedure for high-risk patients [7, 8], but has not been advocated for this age group as a stand-alone technique yet. This article presents the rationale for choosing LSG and its efficacy in a small series of children and adolescents.
Material and Methods
Before surgery was considered, all patients (n = 4, female) had been in a multi-modal weight loss program for several years without significant long-term success. At referral, the mean age was 14.5 years (range 8–17), mean body mass index (BMI in kg/m2) was 48.4 (range 40.6–56.3). An extensive preoperative work-up was performed including EKG, Chest X-ray, laboratory parameters (including blood count, electrolytes, metabolic parameters, thyroid function tests, clotting studies, arterial blood gas), lung function tests, sleep study, upper GI contrast study, and abdominal ultrasound. All suffered from comorbidities as features of a developing metabolic-vascular syndrome such as dislipidemia, cholecystolithiasis, and arterial hypertension (Table 1). Moreover, in the 8-year-old girl, Prader–Willi Syndrome had been confirmed genetically at the age of 2. The decision for bariatric surgery was taken unanimously by the patient, parents, and the obesity team.
LSG was performed according to Milone [9], but using five-trocars only. With a gastroscope (size 40-F) protecting the lesser curvature, the stomach was resected from the proximal antrum to the angle of His using an ENDO-GIA stapler (Autosuture®, green cartridges). That stapler line was then oversewn with 3–0 vicryl. In three girls with preoperatively diagnosed cholecystolithiasis on ultrasound, simultaneous laparoscopic cholecystectomy was performed.
Results
There were no perioperative complications, and all the patients were extubated immediately. An upper GI contrast study on postoperative day 4 documented a J-like tubular gastric remnant (mean volume 76 ml, range 51–100 ml) and ruled out leaks. Thereafter, patients’ were monitored in our special obesity outpatient clinic. After a mean follow-up time of presently 12 months (range 6–19 months) they had reduced the mean BMI from 48.4 to 37.2. The girl with the longest follow-up had reduced her weight from 121 to 83 kg (BMI from 40.6 to 28.4). LSG failed in no child and laboratory studies ruled out malnutrition or vitamin deficiency. Moreover most comorbidities had improved significantly (Table 1).
Discussion
LSG is basically unknown as a stand-alone technique for bariatric surgery in children and adolescents. In adults, however, it is advocated for the treatment of superobese patients to achieve an initial short-term weight loss and improve the perioperative morbidity, before a malabsorptive situation like the RYGB is performed [7, 10]. However, recent data from adult studies [11, 12] suggest that LSG may also be a safe, beneficial, and effective stand-alone approach. Safe because LSG showed minor complications in less than 5% and major complications requiring reoperation in less than 2% of adult patients [13]. Beneficial because Moon [12] reported that LSG led to a resolution of all comorbidities in over 90% of subjects over 12 months except for dislipidemia, which resolved in 65%. Effective because in the same study of 130 relatively young patients (average age 30 years, youngest patient included at 16 years), the mean BMI decreased by 9.2 ± 3.7 kg/m2 after LSG alone. Moreover, there was a striking loss of appetite in more than half of the patients postoperatively [12].
These findings are supported by Himpens, who compared LSG with LAGB in a randomized controlled study [11]. His patients lost significantly more weight 1 and 3 years after LSG and felt much less hungry as well. Loss of appetite may be explained by the fact that ghrelin levels have been shown to decrease significantly after LSG, but not after LAGB as shown by Langer et al. [14]. Ghreline is an acylated gastrointestinal peptide secreted by P/D1 cells predominantly in the fundus of the stomach when fasting. It acts as a potent stimulus for hunger in the arcuate nucleus and is supposed to drive many superobese patients to eat uncontrollably. Since major parts of the stomach are resected during LSG, this approach may actually turn out to be more of an endocrine antiobesity procedure rather than a pure mechanically restrictive operation. Further studies are needed to investigate this aspect prospectively.
The obvious advantages of LSG are effective weight loss without a foreign body and without a life-long dissociation of the gastro-intestinal tract. Critics have contended that LSG may result in long-term dilatation of the remaining stomach sleeve. However, a follow-up study on 23 such patients has refuted this concern, at least over a mean follow-up time of 20 months [15]. Nevertheless, Weiner [16] and other experts agree that the gastric sleeve should not have a volume much larger than 50 ml because weight loss could be insufficient and pouch dilatation may occur. Since our patients showed only a moderate weight loss after 1 year (minus 11 BMI), the mean volume of their sleeves (76 ml) must be observed critically. However, a re-do sleeve is technically feasible and indicated in case of insufficient weight loss [17].
In summary, LSG is a safe and effective alternative for the surgical treatment of morbidly obese adolescents. It may be used as a stand-alone operation. However, longer postoperative follow-up is required before universally recommending this procedure in children and adolescents.
References
Garcia VF, DeMaria EJ. Adolescent bariatric surgery: treatment delayed, treatment denied, a crisis invited. Obes Surg. 2006;16(1):1–4.
Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond). 2007;31(1):1–14.
Fried M, Hainer V, Basdevant A, Weiner R, Widhalm K; Bariatric Scientific Collaborative Group Expert Panel. Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg. 2007 Feb;17(2):260–70.
Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003 Jan;7(1):102–7; discussion 107–8.
Xanthakos SA, Daniels SR, Inge TH. Bariatric surgery in adolescents: an update. Adolesc Med Clin. 2006;17(3):589–612.
Xanthakos SA, Inge TH. Nutritional consequences of bariatric surgery. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):489–96.
Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006 Jun;20(6):859–63.
Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006 Nov;16(11):1445–9.
Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic balloon as a first stage procedure for super-obese patients (BMI > 50). Obes Surg. 2005;15:612–7.
Sileccia G, Boru C, Pecchia A, Rizzello M, Casella G, Leonetti F, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44
Himpens J, Dapri D, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.
Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.
Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–6.
Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.
Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166–71.
Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg. 2007;17:1297–305.
Gagner M, Rogula T. Laparoscopic reoperative sleeve gastrectomy for poor weight loss after biliopancreatic diversion with duodenal switch. Obes Surg. 2003;13:649–54.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Till, H., Blüher, S., Hirsch, W. et al. Efficacy of Laparoscopic Sleeve Gastrectomy (LSG) as a Stand-Alone Technique for Children with Morbid Obesity. OBES SURG 18, 1047–1049 (2008). https://doi.org/10.1007/s11695-008-9543-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-008-9543-6